Introduction
Overview of Ipamorelin and its therapeutic properties
The Ipamorelin Peptide is gaining attention as a growth hormone secretagogue. In scientific research, it has shown promising potential in stimulating the production of growth hormones. This peptide may bring a myriad of potential benefits.
Dosing & Reconstitution Guide
Educational guide for dosing, cycling, cautions, and vial-format options
Ipamorelin is described as the mildest of GHRPs (Growth Hormone Releasing Peptides). It is discussed for stimulating growth hormone (GH) release without increasing appetite, cortisol, or prolactin.
Deeper Research Notes (Summary):
• Stimulates GH release by mimicking ghrelin, binding to GHS-R receptors in the brain, and inhibiting somatostatin (which suppresses GH production).
• Discussed as working on ghrelin receptors to promote GH release without increasing appetite (vs other GHRPs).
• GH support is discussed for muscle growth, fat metabolism, and bone health.
• Has shown potential for boosting insulin release from the pancreas (research discussion).
Dosing & Cycling (As Listed):
| Protocol Item | Guidance |
|---|---|
| Dose | 100–500 mcg per dose |
| Frequency | 1–7× weekly (source notes multiple injections/day may be used to increase GH secretion) |
| Cycle | 8–12 weeks on, then 4–8 weeks off |
| Timing Notes | Carbohydrates and fatty acids may blunt GH release. Often taken 30 minutes before eating or 2 hours after eating. |
Cautions & Contraindications:
Cautions:
• May cause water retention, hunger, headaches, changes in blood sugar level, and joint pain
Contraindications:
• Individuals with active or a history of hormone-sensitive cancers
• Individuals with a history of severe low blood sugar levels
Reconstitution Options (Vial Format):
• 2 mg
• 5 mg
• 10 mg
Reconstitution (General Handling):
• Use sterile technique and sanitize the vial stopper before access.
• Add diluent slowly along the vial wall to minimize foaming.
• Gently swirl/roll until fully dissolved (avoid vigorous shaking).
• Choose a diluent volume that makes a 100–500 mcg dose easy to measure accurately.
• Store according to the product label/spec sheet and protect from light as applicable.
Structure
Molecular composition and structural details of Ipamorelin
Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
Molecular Formula: C38H49N9O5
Molecular Weight: 711.85 g mol−1
Research
Scientific studies on Ipamorelin and its therapeutic applications
Part 1. Ipamorelin Peptide: Overview and How It Works
Ipamorelin is a unique pentapeptide derived from GHRP-1, known for its selective release of growth hormone (GH) while leaving other hormone levels largely unaffected.
Part 2. Pharmacological Study of Ipamorelin Peptide
A comprehensive study has examined the pharmacological profile of Ipamorelin, revealing key insights into its behavior within the human body.
Significant increases in cortical BMC. Expanded femur and vertebra L6 volumes. Increased body weight, cortical bone area, and BMC. Notable improvements in dry defatted weight and bone volume after 12 weeks.
2. Ipamorelin Stimulates Longitudinal Bone Growth in Rats
Ipamorelin positively influenced longitudinal bone growth rate (LGR) and body weight (BW) in rats.
Key findings include:
A shorter median time to the first tolerated meal in the Ipamorelin group, Similar safety and efficacy profiles between Ipamorelin and placebo groups.
Possible side effects may include:
Fluid retention, joint pain, headaches, increased appetite, heightened response to insulin, affecting blood sugar levels.
Ipamorelin is a growth hormone secretagogue. It has selective and potential benefits in bone growth and postoperative ileus management. While some potential side effects have been suggested, further comprehensive research is needed to understand its safety and efficacy fully.
Reviews
There are no reviews yet.